Application of the synthetic PPARγ ligand pioglitazone or the natural PPARγ agonist 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) before ischemia could attenuate lung I/R injury in rats [70, 74]. The gene discussed is PPARG; the disease is ischemia.